Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report)’s stock price dropped 2.2% on Wednesday . The stock traded as low as $0.89 and last traded at $0.90. Approximately 1,084 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 18,311 shares. The stock had previously closed at $0.92.
Fresh Tracks Therapeutics Price Performance
The firm has a 50 day simple moving average of $0.91 and a two-hundred day simple moving average of $0.91. The stock has a market cap of $5.37 million, a price-to-earnings ratio of -0.64 and a beta of 0.35.
Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Free Report) last released its quarterly earnings results on Friday, March 15th. The company reported ($0.20) EPS for the quarter. Fresh Tracks Therapeutics had a negative return on equity of 60.83% and a negative net margin of 91.29%.
Fresh Tracks Therapeutics Company Profile
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
See Also
- Five stocks we like better than Fresh Tracks Therapeutics
- What is Forex and How Does it Work?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Insider Buying Explained: What Investors Need to Know
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
